BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 29, 2000
View Archived Issues
NeoRx's myeloma therapy shows excellent phase II safety results
Read More
La Jolla Pharmaceutical updates progress with lupus drug
Read More
Vical, Human Genome Sciences and Vascular Genetics form collaboration
Read More
Angiotech announces promising results from phase I/II SPMS study
Read More
Unigene achieves milestone in osteoporosis collaboration
Read More
Micardis enters large-scale efficacy trial
Read More
Oxford GlycoSciences highlights principal achievements for 1999
Read More
Medco shareholders approve merger with King Pharmaceuticals
Read More
Selective rotamase inhibitors described by Pfizer for neurological disorders
Read More
Zambon presents new PDE4 inhibitors useful for respiratory diseases
Read More
Hepatitis C product candidate enters phase I testing in U.K.
Read More
New cardiovascular/renal agents under study at SmithKline Beecham
Read More
Tulane team studies gene therapy for pulmonary hypertension
Read More
Bioprojet claims new, orally active histamine H3 antagonists
Read More
Wound-healing gene therapy using NAB2
Read More
New series from American Cyanamid inhibits angiogenesis by targeting VEGF
Read More
Joint effort by OSI, Wyeth-Ayerst results in identification of novel calcitonin-inducing agents
Read More
AdProTech's APT-070 shows encouraging preclinical results in transplantation
Read More
5-HT2C receptor inverse agonists selected for further study in CNS disorders
Read More
Lorus's lead anticancer products reduce tumor growth in mouse models of prostate cancer
Read More
Nycomed Amersham receives approvable letter for extended use of Myoview
Read More
IRB approval received to commence phase II trial of GBC-590
Read More
Abgenix extends antibody collaboration with Pfizer
Read More
Searle identifies novel series of LTA4 hydrolase inhibitors, some with good oral activity
Read More
Safety and efficacy of seocalcitol examined in phase II colorectal cancer study
Read More
Positive early clinical results for decitabine in advanced NSCLC
Read More
Monoclonal antibody targeting Lewis X combined with chemotherapy in breast cancer
Read More
